GLUE vs TEL · rev $13.2M vs P/E 39, rev $17.26B
Monte Rosa Therapeutics Inc (GLUE) versus TE Connectivity Ltd (TEL) — a side-by-side from cached financials, not a winner call.
Monte Rosa Therapeutics Inc (GLUE) is a biotechnology company listed on NASDAQ.
TE Connectivity Ltd (TEL) is a electronic components company listed on US.
Latest reported GLUE revenue for 2026-06-30 was $13.2M. Net income was -$87.9M. GLUE currently screens at market cap $1.56B.
Latest reported TEL revenue for 2025-09-26 was $17.26B. Net income was $1.84B. TEL currently screens at market cap $52.52B and trailing P/E 38.5.
GLUE currently screens at market cap $1.56B. TEL currently screens at market cap $52.52B and trailing P/E 38.5.
Not investment advice. Open the GLUE and TEL stock pages for the full models.
Not investment advice.